Model DetailsBlood vessel hemangiosarcoma
Model Name |
Blood vessel hemangiosarcoma | Strain |
(C57BL/6 x C3H)F1 |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
circulatory system hemangiosarcoma • hemangiosarcoma |
Strain Synonyms |
B6C3F1 • (C57BL/6xC3H) • F1-hybrid B6C3F1 • B6C3F1 • hybrid B6C3F1 • B6C3F1 (C3H x C57B16) • B6C3F1 hybrid |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Blood vessel | Male |
0% (0 of 65 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
0% (0 of 80 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
8.0% (4 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
0% (0 of 60 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
0% (0 of 70 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
8.0% (4 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
0% (0 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
9.2% (6 of 65 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
0% (0 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
2.0% (1 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
0% (0 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
2.0% (1 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
0% (0 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
13% (9 of 70 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
1.5% (1 of 65 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
0% (0 of 80 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
2.0% (1 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
0% (0 of 60 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
0% (0 of 70 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
6.0% (3 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
0% (0 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
3.1% (2 of 65 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
0% (0 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
2.0% (1 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
0% (0 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
2.0% (1 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
2.0% (1 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
5.7% (4 of 70 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
10% (6 of 60 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
10% (6 of 60 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
8.3% (5 of 60 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
12% (7 of 60 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Unspecified |
observed |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
10% (12 of 120 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
10% (12 of 120 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
4% (2 of 50 mice) |
0-2 years |
|
Abdo KM, Arch Toxicol 2003 Dec;77(12):702-11 |
| Blood vessel | Female |
2% (1 of 50 mice) |
0-2 years |
|
Abdo KM, Arch Toxicol 2003 Dec;77(12):702-11 |
| Blood vessel | Male |
4.5% (9 of 200 mice) |
|
Chandra M, Toxicol Lett 1992 Jan;60(1):91-8 | |
| Blood vessel | Female |
1.0% (2 of 200 mice) |
|
Chandra M, Toxicol Lett 1992 Jan;60(1):91-8 | |
| Blood vessel | Male |
5.4% (73 of 1355 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Male |
0% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Male |
12% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Male |
2.5% (28 of 1100 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Male |
0% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Male |
8% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Female |
2.7% (37 of 1353 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Female |
0% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Female |
8% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Female |
2.7% (30 of 1092 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Female |
0% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Female |
8% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Male |
2.7% (64 of 2343 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Blood vessel | Female |
1.9% (48 of 2486 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |